Year: 2026
Type: article
Abstract: Gut microbiota-derived indole metabolites are endogenous signaling molecules that shape host immunity and inflammatory responses. Altered indole metabolism has been associated with inflammatory bowel disease, rheumatoid arthritis, neuroinflammatory disorders, and pulmonary inflammation, as well as with metabolic and neurodegenerative conditions. Their effects are context dependent: indole-3-propionic acid, indole-3-lactic acid, and indole-3-carboxaldehyde generally support immune tolerance, epithelial barrier integrity, antioxidant defenses, and neuroprotection in preclinical models, whereas indole-3-acetic acid can aggravate local lung injury during bacterial pneumonia while limiting pathogen dissemination. This review summarizes the microbial biosynthesis and physiological functions of indole metabolites and examines receptor- and redox-responsive pathways involving the aryl hydrocarbon receptor, pregnane X receptor, and nuclear factor erythroid 2-related factor 2. We also assess clinical association studies, candidate biomarker applications, and dietary, microbial, and pharmacological interventions. Most therapeutic evidence remains preclinical; therefore, prospective cohorts and controlled human trials are needed to establish causality, dosing, efficacy, and long-term safety.
Source: Frontiers in Immunology
Authors: Yichao Jing(Conceptualization, Investigation, Writing – original draft), Jing Zhao(Investigation, Writing – review & editing), Jianing Cao(Investigation, Writing – review & editing), Meina Qiu(Investigation, Writing – review & editing), Lai Pei(Investigation, Writing – review & editing), Hui Liu(Writing – review & editing), Wenting Pan(Conceptualization, Supervision, Writing – review & editing)
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: gut microbiota, indole metabolites, indole-3-propionic acid, indole-3-lactic acid, indole-3-carboxaldehyde, indole-3-acetic acid, aryl hydrocarbon receptor, pregnane X receptor, Nrf2, immune tolerance, epithelial barrier integrity, neuroinflammation, inflammatory bowel disease, rheumatoid arthritis, bacterial pneumonia, lung injury, biomarkers, dietary intervention, microbiota-targeted therapy
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236127478
